Search
for

    Sort by

    Research 19

    1. Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study Frontiers in Cell and Developmental Biology · 2024
    2. The efficacy of scalp-cooling system for the prevention of chemotherapy-induced hair loss in metastatic breast cancer patients treated with eribulin Annals of oncology · 2018
    3. Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review Borneo Journal of Pharmacy · 2025
    4. Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study Drugs - Real World Outcomes · 2019 · 8 citations
    5. Cancer Treatments and Alopecia: A Systematic Review Turkiye Klinikleri Journal of Internal Medicine · 2021 · 2 citations
    6. In silico investigation of possible multi-target drugs against Glutamate S-transferase and prolyl tRNA synthetase in Onchocerca volvulus Open Access Research Journal of Biology and Pharmacy · 2026
    7. Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature 2023
    8. Chemically Induced Hair Loss/Alopecia Springer eBooks · 2019
    9. Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy JNCI Cancer Spectrum · 2019 · 26 citations
    10. Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss Cancers · 2026
    11. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022 Frontiers in Oncology · 2022 · 31 citations
    12. Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer Journal of thoracic oncology · 2010 · 12 citations
    13. Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial The Oncologist · 2024 · 9 citations
    14. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
    15. Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling American Society of Clinical Oncology Educational Book · 2023 · 6 citations
    16. Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia Journal of Market Access & Health Policy · 2024 · 5 citations
    17. Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Drug safety · 2023 · 3 citations
    18. Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study Medicine · 2023 · 1 citations
    19. Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy Bioactive Materials · 2023